Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramin Tadayoni

Showing results (171-180 of 212) with videos related to

Pageof 22
Sort By:
The British Journal of Ophthalmology|September 7, 2014
Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degenerationFrank G Holz, Ramin Tadayoni, Stephen Beatty, et al.
Ophthalmic Research|November 11, 2016
Identifying Predictors of Anti-VEGF Treatment Response in Patients with Neovascular Age-Related Macular Degeneration through Discriminant and Principal Component AnalysisFrank G Holz, Ramin Tadayoni, Stephen Beatty, et al.
Acta Ophthalmologica|July 22, 2014
Ultrasound assessment of ocular vascular effects of repeated intravitreal injections of ranibizumab for wet age-related macular degenerationPhilippe Bonnin, Jean-Antoine C Pournaras, Katarzyna Makowiecka, et al.
Investigative Ophthalmology & Visual Science|February 5, 2017
Protection of Glial Müller Cells by Dexamethasone in a Mouse Model of Surgically Induced Blood-Retinal Barrier BreakdownLourdes Siqueiros-Marquez, Romain Bénard, Ophélie Vacca, et al.
Acta Ophthalmologica|February 12, 2021
Functional and anatomical outcomes after successful repair of macula-off retinal detachment: a 12-month follow-up of the DOREFA studyFlorian Baudin, Clémence Deschasse, Pierre-Henry Gabrielle, et al.
Ophthalmology and Therapy|June 9, 2023
Potential for Treatment Interval Extension in Eyes with nAMD Disease Activity Post Loading Phase in HAWK and HARRIERRamin Tadayoni, Glenn J Jaffe, Frank G Holz, et al.
Retina (Philadelphia, Pa.)|June 16, 2015
TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus RecommendationsK Bailey Freund, Jean-François Korobelnik, Robert Devenyi, et al.
Diagnostics (Basel, Switzerland)|September 9, 2023
Hybrid Fusion of High-Resolution and Ultra-Widefield OCTA Acquisitions for the Automatic Diagnosis of Diabetic RetinopathyYihao Li, Mostafa El Habib Daho, Pierre-Henri Conze, et al.
Elife|July 21, 2016
Subretinal mononuclear phagocytes induce cone segment loss via IL-1βChiara M Eandi, Hugo Charles Messance, Sébastien Augustin, et al.
Glia|March 8, 2021
Reproducing diabetic retinopathy features using newly developed human induced-pluripotent stem cell-derived retinal Müller glial cellsAude Couturier, Guillaume Blot, Lucile Vignaud, et al.
Pageof 22

Showing results (171-180 of 212) with videos related to

Sort By:
Pageof 22
The British Journal of Ophthalmology|September 7, 2014
Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degenerationFrank G Holz, Ramin Tadayoni, Stephen Beatty, et al.
Ophthalmic Research|November 11, 2016
Identifying Predictors of Anti-VEGF Treatment Response in Patients with Neovascular Age-Related Macular Degeneration through Discriminant and Principal Component AnalysisFrank G Holz, Ramin Tadayoni, Stephen Beatty, et al.
Acta Ophthalmologica|July 22, 2014
Ultrasound assessment of ocular vascular effects of repeated intravitreal injections of ranibizumab for wet age-related macular degenerationPhilippe Bonnin, Jean-Antoine C Pournaras, Katarzyna Makowiecka, et al.
Investigative Ophthalmology & Visual Science|February 5, 2017
Protection of Glial Müller Cells by Dexamethasone in a Mouse Model of Surgically Induced Blood-Retinal Barrier BreakdownLourdes Siqueiros-Marquez, Romain Bénard, Ophélie Vacca, et al.
Acta Ophthalmologica|February 12, 2021
Functional and anatomical outcomes after successful repair of macula-off retinal detachment: a 12-month follow-up of the DOREFA studyFlorian Baudin, Clémence Deschasse, Pierre-Henry Gabrielle, et al.
Ophthalmology and Therapy|June 9, 2023
Potential for Treatment Interval Extension in Eyes with nAMD Disease Activity Post Loading Phase in HAWK and HARRIERRamin Tadayoni, Glenn J Jaffe, Frank G Holz, et al.
Retina (Philadelphia, Pa.)|June 16, 2015
TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus RecommendationsK Bailey Freund, Jean-François Korobelnik, Robert Devenyi, et al.
Diagnostics (Basel, Switzerland)|September 9, 2023
Hybrid Fusion of High-Resolution and Ultra-Widefield OCTA Acquisitions for the Automatic Diagnosis of Diabetic RetinopathyYihao Li, Mostafa El Habib Daho, Pierre-Henri Conze, et al.
Elife|July 21, 2016
Subretinal mononuclear phagocytes induce cone segment loss via IL-1βChiara M Eandi, Hugo Charles Messance, Sébastien Augustin, et al.
Glia|March 8, 2021
Reproducing diabetic retinopathy features using newly developed human induced-pluripotent stem cell-derived retinal Müller glial cellsAude Couturier, Guillaume Blot, Lucile Vignaud, et al.
Pageof 22